Skip to content
PubMed This is a summary of 24 peer-reviewed journal articles Updated
Hepatology · Cirrhosis of the Liver

Standard of Care Treatment for Cirrhosis Complications

At a Glance

Standard treatment for cirrhosis complications targets the specific problem: medicines or banding lower bleeding from swollen veins, sodium restriction and diuretics manage ascites, lactulose treats confusion, and TIPS may help when other measures fail.

When cirrhosis progresses, doctors focus on managing specific complications. This “standard of care” involves a combination of medications, dietary changes, and sometimes minimally invasive procedures to prevent life-threatening events [1][2].

Note: Complication control alone does not address the driver of cirrhosis. Disease-specific treatments (such as hepatitis B/C antivirals, complete alcohol abstinence with nonjudgmental medical support, immunosuppressives for autoimmune disease, or metabolic-risk management) are critical at all stages.

Portal Hypertension and Varices

High pressure in the portal vein (portal hypertension) can cause veins in the esophagus to swell into varices, which are at risk of bursting and bleeding [3].

  • Prevention with Beta-Blockers: To lower this pressure, doctors often prescribe non-selective beta-blockers (NSBBs). Carvedilol is frequently preferred for primary prevention in many patients because it effectively lowers portal pressure [1][4]. Other options include propranolol or nadolol [5]. Important Safety Caveat: NSBBs are selected according to your variceal risk, blood pressure, and renal function. They may require holding during hypotension, acute kidney injury, severe hyponatremia, or serious infection. You should not start, stop, or change the dose yourself.
  • Endoscopic Band Ligation (EVL): If beta-blockers aren’t tolerated or if the varices are high-risk, EVL is an alternative where a doctor uses a small rubber band to tie off the swollen veins during an endoscopy [5][3].
  • Treatment of Acute Bleeding: If a bleed occurs, the standard treatment includes immediate hospitalization, medications to slow blood flow to the liver (like octreotide), antibiotics to prevent infection, and urgent endoscopy to stop the bleeding [3][6].

Ascites and Infection (SBP)

Ascites is the buildup of fluid in the abdomen. If this fluid becomes infected, it is called Spontaneous Bacterial Peritonitis (SBP), which is a medical emergency. New ascites, hospitalization with ascites, fever, or abdominal symptoms generally warrant a diagnostic paracentesis to test the fluid for SBP [7].

  • Sodium Restriction: The first step in managing fluid is limiting dietary sodium (salt), usually to less than 2,000 mg per day [8]. (Note: Routine fluid restriction is not required for everyone).
  • Diuretics: “Water pills” like spironolactone and furosemide help the kidneys remove excess fluid [8][2]. Diuretics require clinician monitoring of your kidney function, sodium, potassium, blood pressure, and weight.
  • Paracentesis and Albumin: If fluid buildup is severe, a needle may be used to drain the fluid (paracentesis). When more than 5 liters of fluid are removed, doctors typically provide an intravenous infusion of albumin (approximately 6–8 g per liter removed) to help maintain blood pressure and protect kidney function [9][10].
  • Antibiotics: Antibiotics are used carefully. Diagnostic/treatment antibiotics follow ascitic-fluid testing. Short-course ceftriaxone is used in hospitalized patients with acute variceal bleeding. Secondary prophylaxis is for those with a prior SBP episode. Primary prophylaxis is strictly for selected high-risk patients, and the choice (like norfloxacin) depends on local resistance and allergies [11][12].

Hepatic Encephalopathy (HE) and Nutrition

HE is a decline in brain function that occurs when the liver can no longer remove toxins like ammonia from the blood [13].

  • First-Line Treatment: Lactulose is a syrup that helps move toxins out of the body through the stool. The goal is usually 2 to 3 soft bowel movements per day, but this is individualized. Caution: Excessive watery diarrhea can cause dehydration, electrolyte abnormalities, and kidney injury, which can further worsen encephalopathy. Contact your care team if you have severe diarrhea or no bowel movements [14].
  • Rifaximin: Rifaximin is used as an add-on therapy for the prevention of recurrent overt hepatic encephalopathy despite lactulose use [15].
  • The Protein Myth: You may hear that you should avoid protein to prevent HE, but current medical guidelines strictly advise against protein restriction [16][17]. Muscle loss (sarcopenia) and malnutrition actually make HE worse and increase the risk of death. Patients are encouraged to eat adequate protein and to eat small, frequent meals, including a late-evening snack to prevent the body from breaking down its own muscle for energy [17][18].

Advanced Procedures: TIPS

When medications and diet aren’t enough to control bleeding or fluid buildup, a TIPS (Transjugular Intrahepatic Portosystemic Shunt) may be considered. This procedure creates a “bypass” route for blood through the liver, significantly lowering the pressure in the portal vein [19].

TIPS is highly effective for controlling recurrent bleeding and refractory (stubborn) ascites, but it is not right for everyone [20][21]. Because it allows some blood to bypass the liver’s “filter,” it can increase the risk of confusion (HE) and may strain the heart [22][23]. A thorough evaluation of your heart and brain health is required before this procedure [24].

Common questions in this guide

How can cirrhosis-related variceal bleeding be prevented?
Doctors may use non-selective beta-blockers, often carvedilol, to lower pressure in the portal vein and reduce the risk that swollen esophageal veins will bleed. If these medicines are not tolerated or the varices are high-risk, endoscopic band ligation may be used. Do not start, stop, or change the dose without medical guidance.
What is the usual treatment for ascites in cirrhosis?
Treatment commonly starts with limiting dietary sodium to less than 2,000 mg a day and using diuretics such as spironolactone and furosemide, with monitoring of kidney function, electrolytes, blood pressure, and weight. Severe fluid buildup may require paracentesis, and albumin is typically given when more than 5 liters is removed.
When is testing for spontaneous bacterial peritonitis needed?
A diagnostic paracentesis, which tests abdominal fluid with a needle, is generally needed for new ascites, a hospital admission with ascites, fever, or abdominal symptoms. Spontaneous bacterial peritonitis is a serious infection that requires urgent medical treatment.
Should I avoid protein if I have hepatic encephalopathy?
No. Current guidance advises against restricting protein because muscle loss and poor nutrition can worsen hepatic encephalopathy and increase health risks. Adequate protein, small frequent meals, and a late-evening snack may help protect muscle.
How is lactulose used for confusion from cirrhosis?
Lactulose helps the body remove toxins through bowel movements, and the usual goal is two to three soft stools a day, adjusted by the care team. Severe watery diarrhea can cause dehydration, electrolyte problems, and kidney injury, so contact your care team if diarrhea is severe or you have no bowel movements.
When might a TIPS procedure be recommended?
TIPS may be considered when medicines and diet do not control repeated variceal bleeding or ascites that does not respond to treatment. It can lower portal pressure, but it may increase confusion from hepatic encephalopathy or place strain on the heart, so heart and brain health are assessed beforehand.
Does everyone with cirrhosis need antibiotics to prevent spontaneous bacterial peritonitis?
No. Preventive antibiotics are used for selected high-risk patients, especially people who have had spontaneous bacterial peritonitis before, and the choice depends on factors such as local resistance patterns and allergies. Antibiotics may also be used during hospitalization for acute variceal bleeding or when testing confirms an infection.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Am I currently a candidate for carvedilol, and how will we monitor my blood pressure and heart rate to make sure the dose is right?
  2. 2.If I need a paracentesis, will I be getting albumin, and at what volume of fluid removal does that become necessary?
  3. 3.Is there any specific reason my dietary sodium limit should be different from the standard 2,000 mg per day?
  4. 4.Given my history, should I be taking an antibiotic to prevent an infection like SBP?
  5. 5.How will we decide if or when a TIPS procedure is the right next step for me?
  6. 6.Can you review my protein intake to ensure I am getting enough to prevent muscle loss, even if I have had episodes of confusion?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (24)
  1. 1

    Screening and management of portal hypertension and varices in cirrhosis: Expert perspectives.

    Brown RS, Brown KA, Flamm S, et al.

    Hepatology communications 2025; (9(4)) doi:10.1097/HC9.0000000000000682.

    PMID: 40178492
  2. 2

    Management of Liver Decompensation in Advanced Chronic Liver Disease: Ascites, Hyponatremia, and Gastroesophageal Variceal Bleeding.

    Baiges A, Hernández-Gea V

    Clinical drug investigation 2022; (42(Suppl 1)):25-31 doi:10.1007/s40261-022-01147-5.

    PMID: 35476218
  3. 3

    Endoscopic diagnosis and management of esophagogastric variceal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.

    Gralnek IM, Camus Duboc M, Garcia-Pagan JC, et al.

    Endoscopy 2022; (54(11)):1094-1120 doi:10.1055/a-1939-4887.

    PMID: 36174643
  4. 4

    THE ROLE OF ELASTOGRAPHY IN CLINICALLY SIGNIFICANT PORTAL HYPERTENSION.

    Mattos AA, Mattos AZ, Sartori GDP, et al.

    Arquivos de gastroenterologia 2023; (60(4)):525-535 doi:10.1590/S0004-2803.230402023-64.

    PMID: 38018555
  5. 5

    Primary prophylaxis of variceal bleeding in patients with cirrhosis: A comparison of different strategies.

    de Mattos ÂZ, Terra C, Farias AQ, et al.

    World journal of gastrointestinal endoscopy 2021; (13(12)):628-637 doi:10.4253/wjge.v13.i12.628.

    PMID: 35070024
  6. 6

    Diagnosis and Management of Esophagogastric Varices.

    Pallio S, Melita G, Shahini E, et al.

    Diagnostics (Basel, Switzerland) 2023; (13(6)) doi:10.3390/diagnostics13061031.

    PMID: 36980343
  7. 7

    Emergency medicine updates: Spontaneous bacterial peritonitis.

    Long B, Gottlieb M

    The American journal of emergency medicine 2023; (70()):84-89 doi:10.1016/j.ajem.2023.05.015.

    PMID: 37244043
  8. 8

    Guidelines on the management of ascites in cirrhosis.

    Aithal GP, Palaniyappan N, China L, et al.

    Gut 2021; (70(1)):9-29 doi:10.1136/gutjnl-2020-321790.

    PMID: 33067334
  9. 9

    Management of refractory ascites.

    Wong F

    Clinical and molecular hepatology 2023; (29(1)):16-32 doi:10.3350/cmh.2022.0104.

    PMID: 35676862
  10. 10

    Human Albumin Infusion for the Management of Liver Cirrhosis and Its Complications: An Overview of Major Findings from Meta-analyses.

    Zheng X, Bai Z, Wang T, et al.

    Advances in therapy 2023; (40(4)):1494-1529 doi:10.1007/s12325-023-02430-3.

    PMID: 36697778
  11. 11

    Antibiotic prophylaxis for prevention of spontaneous bacterial peritonitis in liver cirrhosis: systematic review.

    Pimentel R, Gregório C, Figueiredo P

    Acta gastro-enterologica Belgica 2021; (84(2)):333-342 doi:10.51821/84.2.333.

    PMID: 34217185
  12. 12

    Recommendations on the Diagnosis and Initial Management of Acute Variceal Bleeding and Hepatorenal Syndrome in Patients with Cirrhosis.

    Nevens F, Bittencourt PL, Coenraad MJ, et al.

    Digestive diseases and sciences 2019; (64(6)):1419-1431 doi:10.1007/s10620-018-5448-y.

    PMID: 30684079
  13. 13

    New insight on hepatic encephalopathy: a comprehensive review.

    Sedik AA, Alrefaei R

    Journal of basic and clinical physiology and pharmacology 2026; (37(4)):293-303 doi:10.1515/jbcpp-2025-0166.

    PMID: 42206521
  14. 14

    Hepatic Encephalopathy: Definition, Clinical Grading and Diagnostic Principles.

    Weissenborn K

    Drugs 2019; (79(Suppl 1)):5-9 doi:10.1007/s40265-018-1018-z.

    PMID: 30706420
  15. 15

    Understanding the impact of neurologic complications in patients with cirrhosis.

    Allampati SK, Mullen KD

    SAGE open medicine 2019; (7()):2050312119832090 doi:10.1177/2050312119832090.

    PMID: 30834114
  16. 16

    ACG Clinical Guideline: Malnutrition and Nutritional Recommendations in Liver Disease.

    Singal AK, Wong RJ, Dasarathy S, et al.

    The American journal of gastroenterology 2025; (120(5)):950-972 doi:10.14309/ajg.0000000000003379.

    PMID: 40314389
  17. 17

    Reducing the Risk of Overt Hepatic Encephalopathy Recurrence: A Narrative Review.

    Pyrsopoulos NT, Gunn N, Jalal PK, Catinis GE

    Journal of clinical and translational hepatology 2026; (14(6)):674-686 doi:10.14218/JCTH.2025.00698.

    PMID: 42483733
  18. 18

    [Hepatic encephalopathy in liver cirrhosis].

    Labenz C

    Deutsche medizinische Wochenschrift (1946) 2026; (151(4)):149-155 doi:10.1055/a-2647-5748.

    PMID: 41662861
  19. 19

    Refractory Ascites in Liver Cirrhosis.

    Adebayo D, Neong SF, Wong F

    The American journal of gastroenterology 2019; (114(1)):40-47 doi:10.1038/s41395-018-0185-6.

    PMID: 29973706
  20. 20

    Where does TIPS fit in the management of patients with cirrhosis?

    García-Pagán JC, Saffo S, Mandorfer M, Garcia-Tsao G

    JHEP reports : innovation in hepatology 2020; (2(4)):100122 doi:10.1016/j.jhepr.2020.100122.

    PMID: 32671331
  21. 21

    The Role of Transjugular Intrahepatic Portosystemic Shunt for the Management of Ascites in Patients with Decompensated Cirrhosis.

    Iannone G, Pompili E, De Venuto C, et al.

    Journal of clinical medicine 2024; (13(5)) doi:10.3390/jcm13051349.

    PMID: 38592162
  22. 22

    TIPS and hepatic encephalopathy in patients with cirrhosis.

    Bozon-Rivière P, Rudler M, Weiss N, Thabut D

    Metabolic brain disease 2025; (40(2)):117 doi:10.1007/s11011-025-01541-w.

    PMID: 39903376
  23. 23

    Cardiovascular risk assessment and predictors of cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with cirrhosis.

    Tomassoni DR, Schildkraut T, Ramachandran V, et al.

    World journal of gastroenterology 2025; (31(27)):107740 doi:10.3748/wjg.v31.i27.107740.

    PMID: 40741106
  24. 24

    Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data.

    Nicoară-Farcău O, Han G, Rudler M, et al.

    Gastroenterology 2021; (160(1)):193-205.e10 doi:10.1053/j.gastro.2020.09.026.

    PMID: 32980344

This page is for informational purposes only and does not constitute medical advice. Treatment for cirrhosis complications should be individualized with a liver specialist or other qualified healthcare professional.

Get notified when new evidence is published on cirrhosis of liver.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.